BioSpace News Archive

Business

Gottlieb Reflects on His Time as FDA Commissioner, Approval of Dsuvia During the Opioid Crisis

As Scott Gottlieb prepares to step down from his role as commissioner of the U.S. Food and Drug Administration, he sat down with Politico to talk about his two years at the helm of the regulatory agency and what regrets he may be leaving behind.

March 21, 2019
·
3 min read
·
Alex Keown
Policy

Roche Seeks Millions in Diabetes Test Strip Lawsuit

The Roche lawsuit claims that Utah-based Alliance Medical acquired the test strips through a Roche mail order plan and then resold them at a higher price.

March 21, 2019
·
2 min read
·
Alex Keown
Drug Development

Research Roundup: Inactive Drug Ingredients, Whole-Body Regeneration Genes, Alzheimer’s Tests and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

March 21, 2019
·
8 min read
·
Mark Terry
5 Ways to Future-Proof Your Career

Today, one thing is crystal clear: change is the new normal in the life sciences industry. Organizations are looking for leaders who are future-focused and able to handle whatever comes their way. Maintaining the status quo is no longer good enough.

March 21, 2019
·
4 min read
·
Clemson Turregano, Center for Creative Leadership
Drug Development

Biogen Loses $18B in Value as It Kills Aducanumab Alzheimer’s Program

Perhaps the last big hope for a successful Alzheimer’s drug just died. Biogen and its collaboration partner, Eisai, announced they were discontinuing the global Phase III clinical trials of aducanumab in patients with mild cognitive impairment from Alzheimer’s.

March 21, 2019
·
3 min read
·
Mark Terry
Your Feedback Matters! Flexible Options at Work

As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. We want to know your definition of flexible work options.

March 21, 2019
·
1 min read
·
Editorial Staff
Business

Celgene Pays Exscientia $25 Million up Front for 3-Year AI Research Deal

Exscientia will use its full-stack AI drug discovery platform, Centaur Chemist, to accelerate the discovery of small molecule therapeutic drug candidates. It will focus on three of Celgene’s therapeutic programs in oncology and autoimmunity.

March 21, 2019
·
3 min read
·
Mark Terry
Policy

Grocer’s Union Sues AbbVie Over Humira Patents

The United Food and Commercial Workers Local 1500 (UFCW Local 1500) filed a class action lawsuit against AbbVie for allegedly using a group of patents to maintain a monopoly on its blockbuster Humira (adalimumab).

March 21, 2019
·
3 min read
·
Mark Terry
Pharm Country

BioSpace Movers and Shakers: March 22

Biotech and pharma companies make appointments to strengthen executive teams, with moves at Sanofi, Forma, Orchard, CLSA, Sangamo, and more.

March 21, 2019
·
6 min read
·
Alex Keown
Business

Inactive Ingredients Could Be the Reason for a Medicine’s Side Effects

Putting ingredients into a medication that aren’t supposed to have any sort of medically significant effect might seem kind of pointless. However, each of them do serve important purposes.

March 21, 2019
·
3 min read
·
Sasha Mortimer